Background Background The effect of recent
The effect of recent increases in antidepressant prescribing on increases in antidepressant prescribing on population suicide rates is uncertain. population suicide rates is uncertain.
Aims Aims To investigate the relationship
To investigate the relationship between antidepressant sales and trends between antidepressant sales and trends in suicide rates. in suicide rates.
Method Method Graphical and quantitative
Graphical and quantitative assessment of trends in suicide and assessment of trends in suicide and antidepressant sales in Norway, Sweden, antidepressant sales in Norway, Sweden, Denmark and Finland. Denmark and Finland.
Results

Results Suicide rates declined in all four
Suicide rates declined in all four countries during the1990s, whereas countries during the1990s, whereas antidepressant sales increased by 3-to 4-antidepressant sales increased by 3-to 4-fold.Decreasing fold.Decreasing suicide rates in Sweden suicide rates in Sweden and Denmark preceded the rise in antiand Denmark preceded the rise in antidepressant sales byover10 years, although depressant sales byover10 years, although the reductions accelerated between1988 the reductions accelerated between1988 and1990.In Norway, a modest but shortand1990.In Norway, a modest but shortlived decline in suicide rates began around lived decline in suicide rates began around the time of the increase in antidepressant the time of the increase in antidepressant sales.In Finland, decreases in male suicide sales.In Finland, decreases in male suicide rates and to a lesser extent in female rates and to a lesser extent in female suicide rates began around the time of suicide rates began around the time of increased antidepressant sales.In all four increased antidepressant sales.In all four countries decreases in suicide rates countries decreases in suicide rates appeared to precede the widespread use appeared to precede the widespread use of SSRIs. of SSRIs.
Conclusions Conclusions We found mixed evidence
We found mixed evidence that increases in antidepressant sales have that increases in antidepressant sales have coincided with a reduction in coincided with a reduction in the number the number of suicidesin Nordic countries. of suicidesin Nordic countries.
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There are concerns that selective serotonin There are concerns that selective serotonin reuptake inhibitors (SSRIs) may precipitate reuptake inhibitors (SSRIs) may precipitate suicidal behaviour in some individuals suicidal behaviour in some individuals (Healy, 2003) . In the UK, the Medicines (Healy, 2003) . In the UK, the Medicines and Healthcare products Regulatory and Healthcare products Regulatory Agency (MHRA) recently concluded that Agency (MHRA) recently concluded that a modest increase in the risk of self-harm a modest increase in the risk of self-harm in SSRI users could not be ruled out, but in SSRI users could not be ruled out, but that there was too little evidence available that there was too little evidence available to assess the suicide risk (Medicines and to assess the suicide risk (Medicines and Healthcare products Regulatory Agency, Healthcare products Regulatory Agency, 2004) . In contrast, an analysis of secular 2004). In contrast, an analysis of secular trends in antidepressant prescribing and trends in antidepressant prescribing and suicide in the Nordic countries, based suicide in the Nordic countries, based mainly on data for the period 1990-1996, mainly on data for the period 1990-1996, suggests that reductions in the suicide rate suggests that reductions in the suicide rate coincided with increased antidepressant coincided with increased antidepressant prescribing (Isacsson, 2000) . However, prescribing (Isacsson, 2000) . However, time trends in antidepressant prescribing time trends in antidepressant prescribing and suicide in other countries provide conand suicide in other countries provide conflicting evidence for this hypothesis flicting evidence for this hypothesis (Gunnell & Ashby, 2004) . In this paper (Gunnell & Ashby, 2004) . In this paper we update Isacsson's analysis with more we update Isacsson's analysis with more recent data on antidepressant sales and recent data on antidepressant sales and suicide rates in the Nordic countries. In suicide rates in the Nordic countries. In addition, we extend his time series further addition, we extend his time series further back in time to investigate whether the back in time to investigate whether the reductions in suicide in these countries reductions in suicide in these countries coincided with or pre-dated the increases coincided with or pre-dated the increases in antidepressant sales. in antidepressant sales. We plotted separate graphs for each of We plotted separate graphs for each of the four countries to enable us to compare the four countries to enable us to compare the time trends in levels of antidepressant the time trends in levels of antidepressant prescribing with the trends in overall and prescribing with the trends in overall and gender-specific suicide rates. For Norway gender-specific suicide rates. For Norway and Sweden we also plotted age-and and Sweden we also plotted age-and gender-specific suicide rates for three age gender-specific suicide rates for three age groups (15-24, 25-44 and groups (15-24, 25-44 and 4 445 years), as 45 years), as data from other countries suggest that time data from other countries suggest that time trends in suicide rates vary with age trends in suicide rates vary with age (Cantor, 2000) . (Cantor, 2000) .
METHOD METHOD
To estimate the years (with 95% CI) in To estimate the years (with 95% CI) in which changes in trends in suicide rates which changes in trends in suicide rates occurred we used Joinpoint software occurred we used Joinpoint software version 2.7 (available from http://srab.cancer. version 2.7 (available from http://srab.cancer. gov/joinpoint). Join-point regression is a gov/joinpoint). Join-point regression is a form of analysis in which trend data are form of analysis in which trend data are described by a number of contiguous linear described by a number of contiguous linear segments and 'join points' where trends segments and 'join points' where trends change (Kim change (Kim et al et al, 2000) . Permutation tests , 2000) . Permutation tests are used to determine the minimum number are used to determine the minimum number of join points required to provide an of join points required to provide an adequate fit to the data. adequate fit to the data.
RESULTS RESULTS
In all four countries, SSRI sales rose rapidly In all four countries, SSRI sales rose rapidly from around 1991-1993 onwards (Fig. 1) . from around 1991-1993 onwards (Fig. 1) . In Sweden and Norway there was some In Sweden and Norway there was some evidence of a brief compensatory decline evidence of a brief compensatory decline in the sales of other antidepressants, but in the sales of other antidepressants, but this effect was short-lived. The net effect this effect was short-lived. The net effect on overall antidepressant sales of the on overall antidepressant sales of the increase in the use of SSRIs in the 1990s increase in the use of SSRIs in the 1990s was that by 2000 overall levels of antiwas that by 2000 overall levels of antidepressant sales in all four countries were depressant sales in all four countries were 3-to 4-fold greater than in 1990. 3-to 4-fold greater than in 1990.
Norway Norway
The Norwegian statistics show that after a The Norwegian statistics show that after a steady rise in suicide rates throughout the steady rise in suicide rates throughout the 1970s and 1980s, the rates began to decline 1970s and 1980s, the rates began to decline around 1990, which partly coincided with around 1990, which partly coincided with the period when SSRIs were introduced the period when SSRIs were introduced and sales of antidepressants increased and sales of antidepressants increased markedly (Fig. 1a) . However, after 3 years markedly (Fig. 1a) . However, after 3 years of decline (1992) (1993) (1994) , suicide rates then of decline (1992) (1993) (1994) , suicide rates then stabilised, despite large increases in SSRI stabilised, despite large increases in SSRI sales (Fig. 1a) . In age-specific analyses sales (Fig. 1a) . In age-specific analyses ( Fig. 2a and b) it is clear that this reduction ( Fig. 2a and b 
Sweden Sweden
In Sweden, in contrast to Norway, suicide In Sweden, in contrast to Norway, suicide rates have been declining steadily since rates have been declining steadily since the 1970s, many years before the rise the 1970s, many years before the rise in SSRI sales in the early 1990s (Fig. in SSRI sales in the early 1990s (Fig.  1b) , but the decline (again in contrast 1b), but the decline (again in contrast to Norway) also continued after the to Norway) also continued after the introduction of SSRIs in Sweden. It is introduction of SSRIs in Sweden. It is noteworthy that although age-specific noteworthy that although age-specific decreases in suicide rates continued in decreases in suicide rates continued in men and women aged over 25 years men and women aged over 25 years throughout the period of increased SSRI throughout the period of increased SSRI sales, any such declines were less sales, any such declines were less marked marked or absent in individuals aged or absent in individuals aged 15-24 15-24 ( Fig. 2c and d) . As in Norway, there was ( Fig. 2c and d) . As in Norway, there was a reduction in the sales of a reduction in the sales of other antidepressants in the years after other antidepressants in the years after the introduction of SSRIs in Sweden the introduction of SSRIs in Sweden (Fig. 1b) . (Fig. 1b) . 
Denmark Denmark
The Danish statistics ( Fig. 1c) The decline in suicide rates has continued The decline in suicide rates has continued over the period of increased SSRI sales. over the period of increased SSRI sales. However, the rates of decline appeared However, the rates of decline appeared to increase somewhat in the 1990s, to increase somewhat in the 1990s, particularly in women. particularly in women.
Finland Finland
In Finland, after increases in suicide rates in In Finland, after increases in suicide rates in the 1960s, 1970s and 1980s, declines in the the 1960s, 1970s and 1980s, declines in the overall and male suicide rates, and to a overall and male suicide rates, and to a lesser extent in the female suicide rates, lesser extent in the female suicide rates, coincided with the introduction and coincided with the introduction and increased sale of SSRIs (Fig. 1d) . increased sale of SSRIs (Fig. 1d) .
Join-point analysis Join-point analysis
For Norway, Sweden and Denmark the For Norway, Sweden and Denmark the most appropriate model of secular trends most appropriate model of secular trends in suicide rates included two join points in suicide rates included two join points whereas for Finland three join points whereas for Finland three join points provided the best fit to the data. The provided the best fit to the data. The estimated join points and their 95% confiestimated join points and their 95% confidence intervals are shown in Table 1 for dence intervals are shown in Table 1 for models with one, two and three join points, models with one, two and three join points, and the model of best fit is denoted in bold and the model of best fit is denoted in bold type. type. P P-values for a test of the difference in -values for a test of the difference in slopes at each join point in the fitted model slopes at each join point in the fitted model are also shown. are also shown.
For the best-fitting model for Norway, For the best-fitting model for Norway, the 2 years in which changes in trends the 2 years in which changes in trends occurred were 1967 (95% CI 1963 -occurred were 1967 (95% CI 1963 -1991 , when suicide rates began to rise, 1991), when suicide rates began to rise, and 1988 rise, and (95% CI 1985 rise, and -1999 , when suiand 1988 suiand (95% CI 1985 suiand -1999 , when suicide rates began to fall. A third change, cide rates began to fall. A third change, namely the levelling out of rates described namely the levelling out of rates described above, was also identified in 1995 (95% above, was also identified in 1995 (95% CI 1986 -2001 in a model with three join CI 1986-2001) in a model with three join points, although this is not the model of points, although this is not the model of best fit. Similarly, for Sweden 2 years were best fit. Similarly, for Sweden 2 years were identified, namely 1968 (95% CI 1965 -identified, namely 1968 (95% CI 1965 -1970 , when rates began to decline and 1970), when rates began to decline and 1988 (95% CI 1985 -1991 ), when there 1988 (95% CI 1985 -1991 , when there was an accelerated rate of decline as was an accelerated rate of decline as described previously by Carlsten described previously by Carlsten et al et al (2001) . The two join points that were (2001). The two join points that were identified in the Danish suicide data were identified in the Danish suicide data were 1982 (95% CI 1978 -1986 ) and 1989 1982 (95% CI 1978 -1986 ) and 1989 (95% CI 1985 -1995 , the latter year corre- (95% CI 1985 (95% CI -1995 , the latter year corresponding to an increase in the rate of desponding to an increase in the rate of decline that began around 1982. In Finland, cline that began around 1982. In Finland, the best-fitting model included the followthe best-fitting model included the following three join points: 1977 (95% CI ing three join points: 1977 points: (95% CI 1972 points: -1981 , after which suicide rates rose; [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] , after which suicide rates rose; 1983 (95% CI 1979 -1987 ), when rates 1983 (95% CI 1979 -1987 , when rates rose again , and 1990 (95% CI 1988 -rose again, and 1990 (95% CI 1988 -1993 , when they 1993), when they began to fall. In each began to fall. In each of the final (bestof the final (best-fitting) models, fitting) models, P P-values -values provide strong provide strong evidence ( evidence (P P<0.005) for a dif-<0.005) for a difference in slopes ference in slopes at the most recent join at the most recent join point (1988) (1989) (1990) . point (1988) (1989) (1990) .
DISCUSSION DISCUSSION
Trends in suicide rates in Nordic countries Trends in suicide rates in Nordic countries in the 10-year time period before and after in the 10-year time period before and after the introduction of SSRIs provide mixed the introduction of SSRIs provide mixed evidence that increased sales have resulted evidence that increased sales have resulted in a reduction in suicides. In Norway, the in a reduction in suicides. In Norway, the period when the greatest increases in antiperiod when the greatest increases in antidepressant sales occurred was characterised depressant sales occurred was characterised by relatively stable suicide rates. The by relatively stable suicide rates. The decline in suicide rates in Denmark and decline in suicide rates in Denmark and Sweden pre-dated the introduction of the Sweden pre-dated the introduction of the SSRIs by more than 10 years, and the SSRIs by more than 10 years, and the suicide rates in these countries continued suicide rates in these countries continued to decrease thereafter. The strongest to decrease thereafter. The strongest evidence of an association between evidence of an association between increases in antidepressant sales and a increases in antidepressant sales and a decrease in suicide rates was seen in decrease in suicide rates was seen in Finland, where reductions in suicide rates Finland, where reductions in suicide rates coincided with the introduction and coincided with the introduction and increasing use of SSRIs. However, such increasing use of SSRIs. However, such effects were most marked in men, despite effects were most marked in men, despite the fact that women are the greatest consuthe fact that women are the greatest consumers of antidepressants. The decline may mers of antidepressants. The decline may be partly explained by Finland's vigorous be partly explained by Finland's vigorous national suicide prevention programme, national suicide prevention programme, which was initiated around this time which was initiated around this time ( Statistical analysis suggests that in all Statistical analysis suggests that in all four countries a decline (or an acceleration four countries a decline (or an acceleration of a pre-existing decline) in suicide rates of a pre-existing decline) in suicide rates began around [1988] [1989] [1990] . This period began around [1988] [1989] [1990] . This period pre-dates the introduction of SSRIs (and pre-dates the introduction of SSRIs (and certainly their widespread use), although certainly their widespread use), although the 95% confidence intervals for the year the 95% confidence intervals for the year in which suicide rates began to decline in which suicide rates began to decline extend to 1999 for Norway, to 1991 for extend to 1999 for Norway, to 1991 for Sweden, to 1995 for Denmark and to Sweden, to 1995 for Denmark and to 1993 for Finland. These results are derived 1993 for Finland. These results are derived from models that fit linear segments to nonfrom models that fit linear segments to nonlinear data. Although the positions of the linear data. Although the positions of the join points of these segments provide useful join points of these segments provide useful estimates of the years in which trends in estimates of the years in which trends in suicide rates changed significantly, they suicide rates changed significantly, they represent a simplification of the observed represent a simplification of the observed temporal trends, and should therefore be temporal trends, and should therefore be treated with caution. treated with caution.
Our findings contrast with a previous Our findings contrast with a previous assessment of trends in antidepressant assessment of trends in antidepressant 3 5 6 3 5 6 prescribing and suicide rates in the Nordic prescribing and suicide rates in the Nordic countries (Isacsson, 2000) . The limited countries (Isacsson, 2000) . The limited period covered by the suicide data that period covered by the suicide data that were presented in Isacsson's study meant were presented in Isacsson's study meant that it was impossible to distinguish that it was impossible to distinguish between short-term and longer-term trends between short-term and longer-term trends in suicide rate (Isacsson, 2000) . Our in suicide rate (Isacsson, 2000) . Our analysis suggests that the favourable trends analysis suggests that the favourable trends in two of the four countries studied reflect a in two of the four countries studied reflect a longer-term favourable trend in suicide longer-term favourable trend in suicide rates. However, we did find evidence that rates. However, we did find evidence that declining rates of suicide in Sweden accelerdeclining rates of suicide in Sweden accelerated around 1988 ated around 1988, shortly before the wide-, shortly before the widespread use of SSRIs in the 1990s. This spread use of SSRIs in the 1990s. This finding is consistent with another assessfinding is consistent with another assessment of the association between antiment of the association between antidepressant prescribing and suicide rates in depressant prescribing and suicide rates in Sweden up to 1997 which reported that Sweden up to 1997 which reported that the introduction of SSRIs coincided with the introduction of SSRIs coincided with an increased rate of decline in suicide an increased rate of decline in suicide rates (Carlsten rates (Carlsten et al et al, 2001) , but that this , 2001), but that this change pre-dated the large increases in change pre-dated the large increases in antidepressant sales. antidepressant sales.
Prescribing trends and suicide Prescribing trends and suicide rates in other countries rates in other countries
Evidence from other ecological investigaEvidence from other ecological investigations is mixed. The main limitation of those analyses, as well as those in tion of those analyses, as well as those in the present study, is that there are many the present study, is that there are many complex influences on national suicide complex influences on national suicide rates, including the availability of lethal rates, including the availability of lethal methods of suicide, changing social and methods of suicide, changing social and economic conditions, changing levels of economic conditions, changing levels of substance misuse and birth cohort effects substance misuse and birth cohort effects (Gunnell (Gunnell et al et al, 2003) . Distinguishing be-, 2003) . Distinguishing between the discrete effects of changing levels tween the discrete effects of changing levels of antidepressant prescribing and those of of antidepressant prescribing and those of these other influences on patterns of suicide these other influences on patterns of suicide is challenging, as many of the factors are is challenging, as many of the factors are strongly correlated with each other. strongly correlated with each other.
Person-based analyses
Person-based analyses of the association between of the association between antidepressants and suicidal antidepressants and suicidal behaviour behaviour
Recent meta-analyses of placebo-controlled Recent meta-analyses of placebo-controlled randomised trials of SSRIs ( randomised trials of SSRIs (Whittington Whittington et et al al, 2004; Fergusson , 2004; Fergusson et al et al, 2005; Gunnell , 2005; Gunnell et al et al, 2005) have provided evidence that , 2005) have provided evidence that SSRIs are associated with an increased risk SSRIs are associated with an increased risk of non-fatal suicidal behaviour in children of non-fatal suicidal behaviour in children and adults. As most of these trials were of and adults. As most of these trials were of short duration, it is uncertain whether such short duration, it is uncertain whether such increased risks may be offset by a longerincreased risks may be offset by a longerterm reduction in risk among those taking term reduction in risk among those taking antidepressants for the recommended antidepressants for the recommended period of up to 6 months. There were inperiod of up to 6 months. There were insufficient numbers of participants recruited sufficient numbers of participants recruited to the trials to allow investigation of any to the trials to allow investigation of any beneficial or adverse effects of SSRIs on beneficial or adverse effects of SSRIs on suicide deaths (Gunnell suicide deaths (Gunnell et al et al, 2005) , high-, 2005), highlighting the importance of using observalighting the importance of using observational studies to investigate this issue. It is tional studies to investigate this issue. It is noteworthy that observational studies noteworthy that observational studies provide no strong evidence that SSRIs differ provide no strong evidence that SSRIs differ from tricyclic antidepressants with regard from tricyclic antidepressants with regard to the risk of suicidal behaviour (Martinez to the risk of suicidal behaviour (Martinez et al et al, 2005) .
, 2005).
Limitations Limitations
Our analysis has several limitations. First, Our analysis has several limitations. First, we employed an ecological study design we employed an ecological study design using national sources of prescribing and using national sources of prescribing and suicide data. We have not investigated the suicide data. We have not investigated the influence of antidepressant treatment on influence of antidepressant treatment on suicide risk. Furthermore, because the presuicide risk. Furthermore, because the prescribing data are sales data rather than data scribing data are sales data rather than data on person-based consumption of antion person-based consumption of antidepressants, the number of individuals depressants, the number of individuals who took antidepressants will be overwho took antidepressants will be overestimated. Second, we were unable to estimated. Second, we were unable to determine the extent to which increases in determine the extent to which increases in sales were a result of growing numbers of sales were a result of growing numbers of each of the following: people who had been each of the following: people who had been newly prescribed an SSRI; long-term users; newly prescribed an SSRI; long-term users; or a combination of the two. Third, we or a combination of the two. Third, we have not taken into account other influhave not taken into account other influences on temporal trends in suicide rates ences on temporal trends in suicide rates (e.g. changes in the levels of unemploy-(e.g. changes in the levels of unemployment, divorce or substance misuse) (Gunment, divorce or substance misuse) (Gunnell nell et al et al, 2003) . Fourth, we were unable , 2003). Fourth, we were unable to obtain age-and gender-specific prescribto obtain age-and gender-specific prescribing data for the four countries, so we were ing data for the four countries, so we were unable to investigate whether age-specific unable to investigate whether age-specific trends in suicide rates mirrored those for trends in suicide rates mirrored those for prescribing. However, analyses from other prescribing. However, analyses from other countries suggest that antidepressant precountries suggest that antidepressant prescribing increased by 2-fold or more in all scribing increased by 2-fold or more in all age/gender categories in the 1990s age/gender categories in the 1990s (Middleton (Middleton et al et al, 2001; Hall , 2001; Hall et al et al, 2003 Hall et al et al, ), , 2003 , which indicates that our use of all-age data which indicates that our use of all-age data will not seriously bias our interpretation will not seriously bias our interpretation of the overall trends within specific age/ of the overall trends within specific age/ gender categories. Finally, our analysis gender categories. Finally, our analysis was restricted to four countries. As highwas restricted to four countries. As highlighted above, there is mixed evidence from lighted above, there is mixed evidence from other countries concerning the effect of other countries concerning the effect of increased levels of antidepressant prescribincreased levels of antidepressant prescribing on suicide rates. ing on suicide rates.
Implications Implications
Although there is broad consensus about Although there is broad consensus about the effectiveness of SSRIs in treating the effectiveness of SSRIs in treating depression, the evidence that the decline depression, the evidence that the decline in suicide rates which was seen in Norway, in suicide rates which was seen in Norway, Sweden, Denmark and Finland in the 1990s Sweden, Denmark and Finland in the 1990s resulted from increased antidepressant resulted from increased antidepressant prescribing is not clear-cut. A more detailed prescribing is not clear-cut. A more detailed understanding of the factors that have understanding of the factors that have contributed to recent declines in suicide contributed to recent declines in suicide rates in the Nordic countries is required. rates in the Nordic countries is required. Elucidation of these factors will help to Elucidation of these factors will help to inform the development of evidence-based inform the development of evidence-based suicide prevention policies. suicide prevention policies. We have not taken into account other influences on temporal trends in suicide rates (e.g. changes in the levels of unemployment, divorce or substance misuse). rates (e.g. changes in the levels of unemployment, divorce or substance misuse).
& & We were unable to distinguish the extent to which increases in antidepressant
We were unable to distinguish the extent to which increases in antidepressant sales were a result of growing numbers of people who had been newly prescribed a sales were a result of growing numbers of people who had been newly prescribed a selective serotonin reuptake inhibitor, long-term users, or a combination of the two. selective serotonin reuptake inhibitor, long-term users, or a combination of the two.
